Atlas Trials

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Clinical trial NCT06646666 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06646666
Sponsor
Ruijin Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
B-cell Non Hodgkin Lymphoma
Start date
2024-12-01
Primary completion
2027-06-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.